Fundamental Analysis of Ideaya Biosciences Inc - Growth / Value Index


IDYA - Valuation Highlights

Valuation Analysis

   Book Value in last 3 years is trending up
   Tsr Value Index - Very Poor Score of 5.00
   Price to Book Ratio of 1640.31 suggesting that it is very expensive
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -5914.29 -20.62 27.93 %
Price to Book 1589.30 3.75 -21.91 % 3252.28
Price to Sales 49165.50 99.62 202.27 %
Enterprise Value to EBITDA Multiple -18.40 -16.67 40.78 %


IDYA - Profitability Highlights

Profitability Analysis

   Steady Growth in EPS for last four quarters
   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 2.0
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -22.22 -18.19 -8.36 % -4.23
Return On Asset -21.23 -17.40 -15.07 % -4.12
Net Profit Margin -831.30 -483.05 -319.44 % 0
Operating Profit Margin -1026.55 -574.85 -368.43 % 0
EBITDA Margin -1019.96 -557.71 -396.16 % 0


Highlights
Market Cap3065.31 M
Enterprise Value2910.04 M
Price/Book TTM1589.30
Outstanding Share75686.60 K
Float/ Outstanding Share98.89%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score2.00
Altman Z Score64.70
Sloan Ratio0.0035
Peter Lynch Fair Value0


IDYA - Growth Highlights

Growth Analysis

   YoY Net Margin Jump by 319.44%
   Steady increase in Total Assets for last 3 Years
   Tsr Growth Index - Very Poor Score of 12.62
   Quarterly sales in last 5 Quarter is trending down
   Companies' sales dropped by 54.08 % from last year
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 15505.00 K 54.08 % 100.00 %
Gross Profit 13399.00 K 61.95 % 137.32 %
EBITDA -158145.00 K 127.81 % 24.76 %
Net Profit -128893.00 K 92.59 % 16.54 %
EPS -0.0068 38.76 % NA


IDYA - Stability Highlights

Stability Analysis

   Altman Z Score of 66.79 suggests good Stability
   Debt to equity ratio has decreased and is lowest in last three years
   Cash ratio of 23.34
   Company financial liquidity has improved
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -6.26
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.0028 -47.46 % 0.0012
Cash Ratio 23.34 102.94 %
Quick Ratio 0.0007 -99.99 % 28.42
Shareholders Equity 95.65 6.20 %
Debt to EBITDA -0.0134 59.01 %


Historical Valuation Ratios of Ideaya Biosciences Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Ideaya Biosciences Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Ideaya Biosciences Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Ideaya Biosciences Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)